ExploreWatchlistsPricing
  1. JP-listed companies
  2. CHUGAI PHARMACEUTICAL CO., LTD.
  3. Financials
  4. Effective tax rate (%)

CHUGAI PHARMACEUTICAL CO., LTD. (4519)

Market cap
¥14.42T
P/E ratio
35.2x
Chugai Pharmaceutical develops and sells prescription medicines in Japan and internationally, with research operations spanning the US, Europe, and Asia.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEffective tax rate (%) (Million JPY)YoY (%)
Dec 31, 202527.4-4.45%
Dec 31, 202428.7+7.54%
Dec 31, 202326.7-9.63%
Dec 31, 202229.5+6.33%
Dec 31, 202127.8-0.84%
Dec 31, 202028+15.60%
Dec 31, 201924.2+12.84%
Dec 31, 201821.5-1.15%
Dec 31, 201721.7-19.01%
Dec 31, 201626.8+0.67%
Dec 31, 201526.6-16.76%
Dec 31, 201432

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat